This presentation will answer questions repeatedly asked by orthopedic OEMs: Which AM platform technology — EMB or laser — is right for my product? Which laser platform — EOS, 3D Systems, GE Additive or another — is best? Which has the most FDA clearances, and what regulatory considerations do I need to consider relative to the processes?
Many orthopedic companies have prioritized commercializing solutions to combat antimicrobial resistance (AMR). CAM Bioceramics is designing and developing antimicrobial strategies based on calcium phosphates (CaPs) for hard and soft tissues. The company aims to research new technological solutions that prevent AMR.
Artificial Intelligence (AI) enhances the efficiency of dimensional inspections of orthopedic implants. This presentation will highlight the benefits of AI in the quality control process, including increased efficiency and the improved safety and performance of orthopedic implants.
Implantable orthopedic devices have an extensive history with gamma irradiation. This presentation will compare gamma to x-ray, describe similarities and differences, showcase the benefits of adding x-ray sterilization, and discuss considerations in validation and transfers from one radiation technology to another.
Additive manufacturing is now accepted as a manufacturing method for orthopedic implants, but it remains limited to one material for each printing process. This presentation will review state-of-the-art multi-metal printing, including the technical challenges, potential applications, and ways that Amnovis is advancing the technology for the orthopedic industry.